Children’s preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations
Children across a broad age spectrum can provide meaningful input on the palatability preferences of TB drug formulations. Novel MFX formulation blends were recommended for development, but acceptability remains suboptimal.
Authors
- Graeme Hoddinott (ORCID: https://orcid.org/0000-0001-5915-8126)
- Koteswara Rao Inabathina
- Nosivuyile Vanqa (ORCID: https://orcid.org/0000-0002-2774-5622)
- Reshma Taneja (ORCID: https://orcid.org/0000-0001-6214-6177)
- Anneke Catharina Hesseling (ORCID: https://orcid.org/0000-0001-9399-9834)
- Suzanne Staples (ORCID: https://orcid.org/0000-0002-9049-8070)
- Anthony J. Garcia‐Prats (ORCID: https://orcid.org/0000-0002-9280-1950)
- Megan Palmer
- Lario Viljoen (ORCID: https://orcid.org/0000-0003-4039-6639)
- Teviah E. Sachs (ORCID: https://orcid.org/0000-0002-8560-3606)
- Heather R. Draper
- S. Myeni
- M. Raffique
- N. Tshethu
Institutions
- The University of Sydney (AU)
- University of Wisconsin–Madison (US)
- Desmond Tutu HIV Foundation (ZA)
- Stellenbosch University (ZA)
- TB Alliance (US)
- University of Wisconsin Health (US)
- Project Empower (ZA)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2025-04-01
- DOI
- https://doi.org/10.5588/ijtldopen.24.0546
- Citations
- 1
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 3.49